Enoch Chang

Radiation Oncology Resident @MDAndersonNews via @Yale and @SutterHealth

[Fumiko Ladd Chino, MD, FASCO @fumikochino]

Dr @Ansel_PhD at #ASTRO24 on how to better design a clinical trial. If we want our trials to succeed, we should carefully consider how to power them as control arm overperformance is highly prevalent and associated with lower odds of a positive primary endpoint.

[Chelsea C Pinnix MD PhD @ChelseaPinnix]

Our @MDAndersonNews PGY4 resident @StephDudzinski presents study evaluating genomic&path features a/w outcome for SLN+ melanoma pts. No assoc btwn dz outcomes &TERT/ATRX or BRAF mutations but adverse path features=badness.Clinical trial ongoing.Fantastic work! #ASTRO24 @ashleighg

[Albert Koong, MD PhD @ACKoongMDPhD]

Promising initial results of IMMUNOCERV vaccine study in cervical cancer reported by ⁦@adam_grippin⁩ from ⁦@MDAndersonNews⁩. #endcancer #radonc

[Steven H. Lin @StevenLin_MDPhD]

Remarkable innovation by another stellar resident @MDAndersonNews @BenjaminSchrank in @wenjiang_nano lab to enhance anti-tumor immunity through a novel macrophage targeting ADC!! @ACKoongMDPhD @ChelseaPinnix

[Joe Y Chang @JoeChangMD]

What are the biological mechanisms after SABR vs SABR plus IO in early stage NSCLC? Our talented resident @ASeoMDPhD presented different dynamic immunological cytokines profiles in our I-SABR randomized study @MDAndersonNews

[Emma B. Holliday MD @DrEmmaHolliday]

Cullen would be so proud of you @Vince_BernPag
You are a masterful science communicator just like he was. ❤️

[Chelsea C Pinnix MD PhD @ChelseaPinnix]

Congratulations to @MDAndersonNews #RadOnC resident @dr_p_carriere for an outstanding presentation on the 2ndary analysis of the 1,656 low risk prostate cancer pts enrolled on the CEASAR study. Job well done!

[Enoch Chang @Enoch_Chang]

Thank you Dr. Gibbs for joining us here at @MDAndersonNews as a visiting professor! What a privilege to learn from such an inspiring trailblazer in the field

[Adam Grippin @adam_grippin]

Truly honored to cap off the @AACR @ASCO Clinical Trial Workshop with the award for Most Innovative Protocol! Huge thank you to workshop faculty, many new friends, and leadership @MDAndersonNews for supporting this incredible week!

[Albert Koong, MD PhD @ACKoongMDPhD]

Congrats @ebludmir and @ChadTangMD! This @MDAndersonNews P2 randomized study shows PFS of 10.3 mo vs. 2.5 mo in #PancreasCancer pts with oligometastatic dz treated with metastasis-directed therapy+sys tx vs. sys tx alone. #radonc #endcancer https://t.co/LlyGthsSSt

[Albert Koong, MD PhD @ACKoongMDPhD]

Superstar⁩ #radonc resident, ⁦@lee_kamaria⁩, presents results of impact of mobile health technology on health outcomes in Sub-Saharan Africa. ⁦Data presented @MDAndersonNews⁩ and Cancer Diseases Hospital Joint Symposium in #Zambia.

[Nat Lester-Coll, MD @DrLesterColl]

Response-adapted RT led to complete resolution of orbital disease in 90% of patients

@ChelseaPinnix @BouthainaDabaja #radonc
https://t.co/1ul1HyK9kP

[Ramez Kouzy, MD @RKouzyMD]

Our new research highlights patient-level savings using the Mark Cuban Cost Plus Drug Company (MCCPDC) for purchasing generic drugs! This is the first study to quantify individual out-of-pocket savings by opting for MCCPDC over traditional insurance.
https://t.co/l7nB6oPcwf

[The Lancet Haematology @TheLancetHaem]

NEW: Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT #lymphoma: a single-centre, pilot trial @MDAndersonNews #lymsm
https://t.co/1JhqQ81NfM

[Anirban Maitra @Aiims1742]

Congratulations @TaniguchiMD - I know how incredibly proud you are of this @TheLancetOncol study out today. Your paper made the cover highlight!
This was Cullen’s baby from the very preclinical inception in his lab, and it breaks my heart that I can’t shake his hand in person.
Stereotactic body radiotherapy with or without selective dismutase mimetic in #PancreaticCancer: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial.
https://t.co/q4FmfjxCru
Cc: @ACKoongMDPhD @PrajnanDasMD @colbertle @aguilera_md @DrShubhamPant @Vince_BernPag @ebludmir @eugenekoay

[Lauren E. Colbert, MD MSCR @colbertle]

1/ 🔬🧫Tumoral lactic acid bacteria can rewire tumor metabolism and drive cancer treatment response. Our @cancercell paper is finally out #openaccess online! 🦠🔬
https://t.co/N85xQegPbt

[Ramez Kouzy, MD @RKouzyMD]

Still reeling from the news about @TaniguchiMD . He was the best of us. A remarkable soul whose selflessness and kindness touched many, myself included. CT loved a good tweetorial, so in seeking words, I'll share memories of him. #RememberingCT

[Joe Y Chang @JoeChangMD]

Randomized study published in Lancet today, showing 62% EFS improvement with Nivo + SABR compared with SABR alone in early stage NSCLC. I-SABR is a promising TX option.

awbs://authors.elsevier.com/c/1hRV5V-4XL3dJ
@IASLC
@MDAndersonNews @TheLancet @ACKoongMDPhD
@StephenVLiu

[Denise De la Cruz, Ed.D. @yogagirldd]

Happy #MatchDay2021‼️ Congrats and welcome 🙌🏼 @MDAndersonNews #radonc #residency #Classof2026 to the #workfam ☢️💛 @ChelseaPinnix @DrEmmaHolliday @StephDudzinski @RKouzyMD @adam_grippin @Enoch_Chang @cd_fuller @TaniguchiMD